The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina
Open accessAbstract
Adeno-associated viral vectors reconstitute large proteins in the retina via intein-mediated protein trans-splicing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Upon subretinal AAV administration, split inteins catalyze the seamless joining of the two halves of the ABCA4 protein, thus reconstituting a functional full-length ABCA4 protein in photoreceptors, at levels that largely exceed those achieved via AAV genome recombination by alternative dual AAV-based strategies (5), resulting in therapeutic efficacy in Abca4−/− mice (5).”
From Retinal gene therapy for Stargardt disease with dual AAV intein vectors is both safe and effective in large animal models (2025) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“resulting in therapeutic efficacy in Abca4−/− mice (5).”
From Retinal gene therapy for Stargardt disease with dual AAV intein vectors is both safe and effective in large animal models (2025) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“at levels that largely exceed those achieved via AAV genome recombination by alternative dual AAV-based strategies (5), resulting in therapeutic efficacy in Abca4−/− mice (5).”
From Retinal gene therapy for Stargardt disease with dual AAV intein vectors is both safe and effective in large animal models (2025) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“To overcome this limitation, we have recently developed a dual AAV gene therapy approach, which we named “AAV-ABCA4-intein” vectors (5).”
From Retinal gene therapy for Stargardt disease with dual AAV intein vectors is both safe and effective in large animal models (2025) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Overall, these data show a good safety and expression profile of AAV8.ABCA4.intein vectors in the NHP retina, confirming the promising data from a previous study in mouse models (5).”
From Retinal gene therapy for Stargardt disease with dual AAV intein vectors is both safe and effective in large animal models (2025) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Although some of these studies have revealed amelioration of retinal phenotypes in STGD1 mouse models [29,64,102], the low transduction efficiencies as well as the aberrant production of truncated proteins from single AAV vectors have been two major limitations [103,104].”
From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [64]
The cited source says what the claim attributes to it.
In the citing paper
“Recently, the Auricchio lab explored the potentials of protein trans-splicing for inherited retinal disorders, proving this technology to achieve superior reassembly efficiencies as compared to other dual AAV vector strategies [64].”
From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [64]
The cited source says what the claim attributes to it.
In the citing paper
“Finally, the use of inteins has also been explored at the experimental level: AAV2/8-CEP290 protein trans-splicing vectors have achieved reconstitution of the large CEP290 protein in the mouse retina, showing ameliorated retinal phenotypes [64].”
From Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders (2022) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Organoid Models and Applications in Biomedical Research
Xinaris, C., Brizi, V., & Remuzzi, G. (2015) · The Nephron journals/Nephron journals · doi:10.1159/000433566 · Cited by 3,519
Self-formation of optic cups and storable stratified neural retina from human ESCs
Nakano, T., Ando, S., Takata, N., Kawada, M., Muguruma, K., Sekiguchi, K., Saito, K., Yonemura, S., Eiraku, M., & Sasai, Y. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.05.009 · Cited by 1,447
Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs
Zhong, X., Gutierrez, C., Xue, T., Hampton, C., Vergara, M. N., Cao, L.-H., Peters, A., Park, T. S., Zambidis, E. T., Meyer, J. S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5047 · Cited by 970
Weng, J., Mata, N. L., Azarian, S. M., Tzekov, R. T., Birch, D. G., & Travis, G. H. (1999) · Cell · doi:10.1016/s0092-8674(00)80602-9 · Cited by 881 · cited 1×
“Three months later, we harvested the eyes and performed transmission electron microscopy analysis of retinal ultrathin sections to measure the amounts of lipofuscin, which accumulates in the RPE of Abca4−/− mice (26, 27).”
MethodTreatment of a metabolic liver disease by in vivo genome base editing in adult mice
Villiger, L., Grisch‐Chan, H. M., Lindsay, H. A., Ringnalda, F. C. A. S., Pogliano, C. B., Allegri, G., Fingerhut, R., Häberle, J., Matos, J., Robinson, M. D., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0209-1 · Cited by 426
Inteins: nature's gift to protein chemists
Shah, N. H., & Muir, T. W. (2014) · Chem. Sci. · doi:10.1039/c3sc52951g · Cited by 404
Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element
Donello, J. E., Loeb, J. E., & Hope, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.5085-5092.1998 · Cited by 350
Chang, B., Khanna, H., Hawes, N., Jimeno, D., He, S., Lillo, C., Parapuram, S. K., Cheng, H., Scott, A., Hurd, R. E., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl107 · Cited by 328
Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy
Yan, Z., Zhang, Y., Duan, D., & Engelhardt, J. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6716 · Cited by 305
Auricchio, A., Hildinger, M., O'Connor, E., Gao, G., & Wilson, J. M. (2001) · Human Gene Therapy · doi:10.1089/104303401450988 · Cited by 296
Self-citation
Cited by
Sorted by citations
Engineering adeno-associated virus vectors for gene therapy
Li, C., & Samulski, R. J. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0205-4 · Cited by 1,175
AAV vectors: The Rubik’s cube of human gene therapy
Pupo, A., Fernández, A., Low, S. H., François, A., Suárez-Amarán, L., & Samulski, R. J. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.09.015 · Cited by 382
Chemoenzymatic Semisynthesis of Proteins
Thompson, R. E., & Muir, T. W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00450 · Cited by 245
Bucher, K., Rodríguez-Bocanegra, E., Dauletbekov, D., & Fischer, M. D. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100915 · Cited by 242
Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing
Chemello, F., Chai, A. C., Li, H. Z., Rodríguez-Caycedo, C., Sanchez‐Ortiz, E., Atmanli, A., Mireault, A. A., Liu, N., Bassel‐Duby, R., & Olson, E. N. (2021) · Science Advances · doi:10.1126/sciadv.abg4910 · Cited by 255
Drug delivery systems for CRISPR-based genome editors
Madigan, V. J., Zhang, F., & Dahlman, J. E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00762-x · Cited by 193
Next-generation AAV vectors—Do not judge a virus (only) by its cover
Domenger, C., & Grimm, D. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz148 · Cited by 147
Viral Vectors for the in Vivo Delivery of CRISPR Components: Advances and Challenges
Mengstie, M. A. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.895713 · Cited by 146
Advances in gene therapy hold promise for treating hereditary hearing loss
Jiang, L., Wang, D., He, Y., & Shu, Y. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.001 · Cited by 125
Adeno-Associated Viral Vectors in Neuroscience Research
Haggerty, D. L., Grecco, G. G., Reeves, K. C., & Atwood, B. K. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.11.012 · Cited by 135
Challenges for Therapeutic Applications of Opsin-Based Optogenetic Tools in Humans
Shen, Y., Campbell, R. E., Côté, D. C., & Paquet, M.-È. (2020) · Frontiers in Neural Circuits · doi:10.3389/fncir.2020.00041 · Cited by 119
O’Carroll, S. J., Cook, W. H., & Young, D. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.618020 · Cited by 112
An expanded library of orthogonal split inteins enables modular multi-peptide assemblies
Pinto, F., Thornton, E. L., & Wang, B. (2020) · Nature Communications · doi:10.1038/s41467-020-15272-2 · Cited by 103
Hearing of Otof-deficient mice restored by trans-splicing of N- and C-terminal otoferlin
Tang, H., Wang, H., Wang, S., Hu, S. W., Lv, J., Xun, M., Gao, K., Wang, F., Chen, Y., Wang, D., et al. (2022) · Human Genetics · doi:10.1007/s00439-022-02504-2 · Cited by 86
Suprachoroidal delivery of viral and nonviral gene therapy for retinal diseases
Kansara, V., Muya, L., Wan, C.-R., & Ciulla, T. A. (2020) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2019.0126 · Cited by 84
mRNA trans-splicing dual AAV vectors for (epi)genome editing and gene therapy
Riedmayr, L. M., Hinrichsmeyer, K. S., Thalhammer, S. B., Mittas, D. M., Karguth, N., Otify, D. Y., Böhm, S., Weber, V. J., Bartoschek, M. D., Splith, V., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42386-0 · Cited by 92
Can Adeno-Associated Viral Vectors Deliver Effectively Large Genes?
Tornabene, P., & Trapani, I. (2020) · Human Gene Therapy · doi:10.1089/hum.2019.220 · Cited by 76
Self-citationSplit intein-mediated protein trans-splicing to express large dystrophins
Tasfaout, H., Halbert, C. L., McMillen, T. S., Allen, J. M., Reyes, T. R., Flint, G. V., Grimm, D., Hauschka, S. D., Regnier, M., & Chamberlain, J. S. (2024) · Nature · doi:10.1038/s41586-024-07710-8 · Cited by 82
Shubina-Oleinik, O., Nist-Lund, C. A., French, C. E., Rockowitz, S., Shearer, A. E., & Holt, J. R. (2021) · Science Advances · doi:10.1126/sciadv.abi7629 · Cited by 67
Evolving AAV-delivered therapeutics towards ultimate cures
He, X., Urip, B. A., Zhang, Z., Ngan, C. C., & Feng, B. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-020-02034-2 · Cited by 70
Protein Splicing of Inteins: A Powerful Tool in Synthetic Biology
Wang, H., Wang, L., Zhong, B., & Dai, Z. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.810180 · Cited by 59
AAV for Gene Therapy in Ocular Diseases: Progress and Prospects
He, X., Fu, Y., Ma, L., Yao, Y., Ge, S., Yang, Z. H., & Fan, X. (2023) · Research · doi:10.34133/research.0291 · Cited by 66
Marrone, L., Marchi, P. M., & Azzouz, M. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2012148 · Cited by 56
“Although some of these studies have revealed amelioration of retinal phenotypes in STGD1 mouse models [29,64,102], the low”
BackgroundResultHigh-efficiency base editing in the retina in primates and human tissues
Muller, A., Sullivan, J., Schwarzer, W., Wang, M., Park-Windhol, C., Hasler, P. W., Janeschitz-Kriegl, L., Duman, M., Klingler, B., Matsell, J., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03422-8 · Cited by 52
Kolesnik, V. V., Nurtdinov, R. F., Oloruntimehin, E. S., Karabelsky, A. V., & Malogolovkin, A. S. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1607 · Cited by 53
Wang, J.-H., Zhan, W., Gallagher, T. L., & Gao, G. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.10.017 · Cited by 51
Wagner, H. J., Weber, W., & Fussenegger, M. (2021) · Advanced Science · doi:10.1002/advs.202004018 · Cited by 52
Therapy Approaches for Stargardt Disease
Piotter, E., McClements, M. E., & MacLaren, R. E. (2021) · Biomolecules · doi:10.3390/biom11081179 · Cited by 49
Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model
Patrizi, C., Llado-Santaeularia, M., Benati, D., Iodice, C., Marrocco, E., Guarascio, R., Surace, E. M., Cheetham, M. E., Auricchio, A., & Recchia, A. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.01.006 · Cited by 51
Self-citationMaybe you can turn me on: CRISPRa-based strategies for therapeutic applications
Bećirović, E. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04175-8 · Cited by 52
Gene therapy for inherited arrhythmias
Bezzerides, V. J., Prondzynski, M., Carrier, L., & Pu, W. T. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa107 · Cited by 45
Kaltak, M., de Bruijn, P., Piccolo, D., Lee, S.-E., Dulla, K., Hoogenboezem, T., Beumer, W., Webster, A. R., Collin, R. W. J., Cheetham, M. E., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.02.020 · Cited by 45
Retinal organoids as models for development and diseases
Zhang, X., Wang, W., & Jin, Z. (2021) · Cell Regeneration · doi:10.1186/s13619-021-00097-1 · Cited by 45
Gene therapy for monogenic disorders: challenges, strategies, and perspectives
Zhang, Y., & Wu, Z. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.08.001 · Cited by 43
Hair Cell Transduction Efficiency of Single- and Dual-AAV Serotypes in Adult Murine Cochleae
Omichi, R., Yoshimura, H., Shibata, S. B., Vandenberghe, L. H., & Smith, R. J. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.05.007 · Cited by 43
Wagstaff, E. L., Berzal, A. H., Boon, C. J. F., Quinn, P. M. J., ten Asbroek, A. L. M. A., & Bergen, A. A. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137081 · Cited by 44
Adeno-Associated Virus-Based Gene Therapy for Lifelong Correction of Genetic Disease
Brommel, C. M., Cooney, A. L., & Sinn, P. L. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.138 · Cited by 43
Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges
Falabella, M., Minczuk, M. A., Hanna, M. G., Viscomi, C. F., & Pitceathly, R. D. S. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00715-9 · Cited by 42
Kurzawa‐Akanbi, M., Tzoumas, N., Corral-Serrano, J. C., Guarascio, R., STEEL, D. H., Cheetham, M. E., Armstrong, L., & Lako, M. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101248 · Cited by 41
Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
Mbakam, C. H., Lamothe, G., & Tremblay, J. P. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.859930 · Cited by 46
Optimized Adeno-Associated Virus Vectors for Efficient Transduction of Human Retinal Organoids
Völkner, M., Pavlou, M., Büning, H., Michalakis, S., & Karl, M. (2021) · Human Gene Therapy · doi:10.1089/hum.2020.321 · Cited by 39
Gene Therapy Potential for Genetic Disorders of Surfactant Dysfunction
Cooney, A. L., Wambach, J., Sinn, P. L., & McCray, P. B. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.785829 · Cited by 42
Tremblay, G., Rousseau, J., Mbakam, C. H., & Tremblay, J. P. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0085 · Cited by 37
Gene therapy for cardiac diseases: methods, challenges, and future directions
Grisorio, L., Bongianino, R., Gianeselli, M., & Priori, S. G. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae207 · Cited by 36
Wood, D. W., Belfort, M., & Lennon, C. W. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1305848 · Cited by 34
Viral vectors for gene delivery to the inner ear
Maguire, C. A., & Corey, D. P. (2020) · Hearing Research · doi:10.1016/j.heares.2020.107927 · Cited by 33
A Review of Gene, Drug and Cell-Based Therapies for Usher Syndrome
French, L. S., Mellough, C., Chen, F. K., & Carvalho, L. S. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00183 · Cited by 34
Hair cell-specific Myo15 promoter-mediated gene therapy rescues hearing in DFNB9 mouse model
Wang, H., Xun, M., Tang, H., Zhao, J., Hu, S., Zhang, L., Lv, J., Wang, D., Chen, Y., Liu, J., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102135 · Cited by 34
Therapeutic applications oftrans-splicing
Hong, E. M., Ingemarsdotter, C. K., & Lever, A. M. L. (2020) · British Medical Bulletin · doi:10.1093/bmb/ldaa028 · Cited by 32
Organoids and microphysiological systems: Promising models for accelerating AAV gene therapy studies
Ramamurthy, R. M., Atala, A., Porada, C. D., & Almeida-Porada, G. D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1011143 · Cited by 35
Full-length ATP7B reconstituted through protein trans-splicing corrects Wilson disease in mice
Padula, A., Petruzzelli, R., Philbert, S. A., Church, S. J., Esposito, F., Campione, S., Monti, M., Capolongo, F., Perna, C., Nusco, E., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.08.004 · Cited by 31
Self-citationEffective gene therapy of Stargardt disease with PEG-ECO/pGRK1-ABCA4-S/MAR nanoparticles
Sun, D., Sun, W., Gao, S., Lehrer, J., Naderi, A., Wei, C., Lee, S.-J., Schilb, A. L., Scheidt, J. H., Hall, R. C. W., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.08.026 · Cited by 31
Sladen, P. E., Naeem, A., Adefila-Ideozu, T., Vermeule, T., Busson, S. L., Michaelides, M., Naylor, S., Forbes, A. J., Lane, A., & Georgiadis, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031839 · Cited by 30
Large gene delivery to the retina with AAV vectors: are we there yet?
Trapani, I., Tornabene, P., & Auricchio, A. (2020) · Gene Therapy · doi:10.1038/s41434-020-0174-4 · Cited by 30
Self-citationdCas9-VPR-mediated transcriptional activation of functionally equivalent genes for gene therapy
Riedmayr, L. M., Hinrichsmeyer, K. S., Karguth, N., Böhm, S., Splith, V., Michalakis, S., & Bećirović, E. (2022) · Nature Protocols · doi:10.1038/s41596-021-00666-3 · Cited by 33
Molinari, E., Ramsbottom, S. A., Srivastava, S., Booth, P., Alkanderi, S., McLafferty, S., Devlin, L. A., White, K., Gunay‐Aygun, M., Miles, C. G., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47243-z · Cited by 32
Gene therapy in color vision deficiency: a review
Moussawi, Z. E., Boueiri, M., & Al‐Haddad, C. (2021) · International Ophthalmology · doi:10.1007/s10792-021-01717-0 · Cited by 29
Gene editing prospects for treating inherited retinal diseases
Benati, D., Patrizi, C., & Recchia, A. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106473 · Cited by 28
Clinical and Translational Landscape of Viral Gene Therapies
Yudaeva, A., Kostyusheva, A., Kachanov, A., Brezgin, S., Ponomareva, N., Parodi, A., Pokrovsky, V. S., Lukashev, A. N., Chulanov, V., & Kostyushev, D. S. (2024) · Cells · doi:10.3390/cells13221916 · Cited by 30
Carrella, S., Guida, M. D., Brillante, S., Piccolo, D., Ciampi, L., Guadagnino, I., García‐Piqueras, J., Pizzo, M., Marrocco, E., Molinari, M., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202215941 · Cited by 26
Self-citationTornabene, P., Trapani, I., Centrulo, M., Marrocco, E., Minopoli, R., Lupo, M., Iodice, C., Gesualdo, C., Simonelli, F., Surace, E. M., et al. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.10.004 · Cited by 25
Self-citationGenetics and gene therapy in Dravet syndrome
Higurashi, N., Broccoli, V., & Hirose, S. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.108043 · Cited by 26
Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases
Hansen, S., McClements, M. E., Corydon, T. J., & MacLaren, R. E. (2023) · Cells · doi:10.3390/cells12030440 · Cited by 25
Cav1.4 dysfunction and congenital stationary night blindness type 2
Koschak, A., Fernández‐Quintero, M. L., Heigl, T., Ruzza, M. R. D., Seitter, H., & Zanetti, L. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02570-x · Cited by 24
Successful large gene augmentation of USH2A with non-viral episomal vectors
Toms, M., Toualbi, L., Almeida, P. V., Harbottle, R. P., & Moosajee, M. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.06.012 · Cited by 24
Retina-directed gene therapy: Achievements and remaining challenges
Biber, J., Gandor, C. L. A., Bećirović, E., & Michalakis, S. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108862 · Cited by 25
Inteins as Drug Targets and Therapeutic Tools
Tharappel, A. M., Li, Z., & Li, H. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.821146 · Cited by 20
Organoids – the future of pre-clinical development of AAV gene therapy for CNS disorders
Kaiser, V., & Gonzalez-Cordero, A. (2025) · Gene Therapy · doi:10.1038/s41434-025-00527-8 · Cited by 19
Gene therapy for age-related macular degeneration: a promising frontier in vision preservation
Hushmandi, K., Lam, H. Y., Wong, W., Tan, W., Daryabari, S., Reiter, R. J., Farahani, N., & Kumar, A. P. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02246-4 · Cited by 25
Split AAV8 Mediated ABCA4 Expression for Gene Therapy of Mouse Stargardt Disease (STGD1)
Li, R., Jing, Q., She, K., Wang, Q., Jin, X., Zhao, Q., Su, J., Song, L., Fu, J., Wu, X., et al. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.017 · Cited by 21
Corydon, T. J., & Bek, T. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101323 · Cited by 20
CRISPR Systems Suitable for Single AAV Vector Delivery
Stevanovic, M., Piotter, E., McClements, M. E., & MacLaren, R. E. (2021) · Current Gene Therapy · doi:10.2174/1566523221666211006120355 · Cited by 19
Angeli, P. D., Reuter, P., Hauser, S., Schöls, L. J., Štingl, K., Wissinger, B., & Kohl, S. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.07.023 · Cited by 20
Ferla, R., Pugni, E., Lupo, M., Tiberi, P., Fioretto, F., Perota, A., Duchi, R., Lagutina, I., Gesualdo, C., Rossi, S., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt9354 · Cited by 19
Self-citationHuang, J., Li, J., Xu, X., & Li, K. (2025) · Biomolecules · doi:10.3390/biom15070940 · Cited by 18
Inteins: A Swiss army knife for synthetic biology
Anastassov, S., Filo, M., & Khammash, M. (2024) · Biotechnology Advances · doi:10.1016/j.biotechadv.2024.108349 · Cited by 23
Delivering large genes using adeno-associated virus and the CRE-lox DNA recombination system
Datta, P., Rhee, K.-D., Staudt, R. J., Thompson, J. M., Hsu, Y., Hassan, S., Drack, A. V., & Seo, S. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae144 · Cited by 17
In vivo liver targeted genome editing as therapeutic approach: progresses and challenges
Simoni, C., Barbon, E., Muro, A. F., & Cantore, A. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1458037 · Cited by 20
The ABCs of Stargardt disease: the latest advances in precision medicine
Zaydon, Y. A., & Tsang, S. H. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01272-y · Cited by 20
Retinal Organoids: Innovative Tools for Understanding Retinal Degeneration
Galindo‐Cabello, N., Caballano‐Infantes, E., Benites, G., Pastor‐Idoate, S., Diaz-Corrales, F. J. J., & Usategui‐Martín, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073263 · Cited by 16
Macdonald, J., Marx, J., & Büning, H. (2021) · Human Gene Therapy · doi:10.1089/hum.2021.169 · Cited by 17
Ferreira, M. V., Fernandes, S., Almeida, A. I., Neto, S., Mendes, J. P., Silva, R. J. S., Peixoto, C., & Coroadinha, A. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310524 · Cited by 16
Purde, V., Kudryashova, E., Heisler, D. B., Shakya, R., & Kudryashov, D. S. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006603117 · Cited by 16
Liver-directed gene-based therapies for inborn errors of metabolism
Piccolo, P., Rossi, A., & Brunetti‐Pierri, N. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1817375 · Cited by 16
Tasfaout, H., McMillen, T. S., Reyes, T. R., Halbert, C. L., Tian, R., Regnier, M., & Chamberlain, J. S. (2025) · Journal of Clinical Investigation · doi:10.1172/jci189075 · Cited by 16
Riaz, S., Sethna, S., Duncan, T. E., Naeem, M. A., Redmond, T. M., Riazuddin, S. A., Riazuddin, S., Carvalho, L. S., & Ahmed, Z. M. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.10.017 · Cited by 15
Duncan, J. L., Bowman, A. N., Laster, A., Gelfman, C. M., Birch, D. G., Boye, S. L., Daiger, S. P., Priore, L. V. D., Zack, D. J., & Handa, J. T. (2024) · Translational Vision Science & Technology · doi:10.1167/tvst.13.12.28 · Cited by 15
Gene Therapy for Hearing Loss: Which Genes Next?
Carlson, R. J., Taiber, S., & Rubinstein, J. T. (2025) · Otology & Neurotology · doi:10.1097/mao.0000000000004423 · Cited by 15
Dual AAV vectors for efficient delivery of large transgenes
Mittas, D. M., Riedmayr, L. M., Gavrilov, Z., Weber, V. J., Otify, D. Y., Mehlfeld, V., Szalontai, B., Ucambarlic, E., Gandor, C. L. A., Heigl, T., et al. (2025) · Nature Protocols · doi:10.1038/s41596-025-01243-8 · Cited by 18
Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trials
Staedtke, V., Anstett, K., Bedwell, D. M., Giovannini, M., Keeling, K. M., Kesterson, R. A., Kim, Y., Korf, B. R., Leier, A., McManus, M. L., et al. (2023) · Clinical Trials · doi:10.1177/17407745231207970 · Cited by 14
A functional mini-GDE transgene corrects impairment in models of glycogen storage disease type III
Gardin, A., Rouillon, J., Montalvo-Romeral, V., Rossiaud, L., Vidal, P., Launay, R., Vie, M., Benchekroun, Y. K., Cosette, J., Bertin, B., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci172018 · Cited by 18
Retinal Ciliopathies and Potential Gene Therapies: A Focus on Human iPSC-Derived Organoid Models
McDonald, A. J., & Wijnholds, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052887 · Cited by 16
Engineering adeno-associated viral vectors for CRISPR/Cas based in vivo therapeutic genome editing
Moyo, B., Brown, L. B. C., Khondaker, I., & Bao, G. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123314 · Cited by 13
Liver gene therapy with intein‐mediated F8 trans‐splicing corrects mouse haemophilia A
Esposito, F., Lyubenova, H., Tornabene, P., Auricchio, S., Iuliano, A., Nusco, E., Merlin, S., Olgasi, C., Manni, G., Gargaro, M., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202115199 · Cited by 12
Self-citationGeneration of Human iPSC-Derived Retinal Organoids for Assessment of AAV-Mediated Gene Delivery
Tso, A., da Costa, B. L., Fehnel, A., Levi, S. R., Jenny, L. A., Ragi, S. D., Li, Y., & Quinn, P. M. J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2651-1_27 · Cited by 13
Wu, F., He, W., Xiao, Y., Wu, Q., Zhang, Q., Zhang, T., Xu, L., & Pang, X. (2025) · Advanced Science · doi:10.1002/advs.202408397 · Cited by 12
Tsai, Y.-T., da Costa, B. L., Nolan, N. D., Caruso, S. M., Jenny, L. A., Levi, S. R., Tsang, S. H., & Quinn, P. M. J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2651-1_29 · Cited by 12
Shining light on CRISPR/Cas9 therapeutics for inherited retinal diseases
Geiger, A., Kennedy, J. G., Staker, L. G., Wensel, T. G., Casson, R. J., & Thomas, P. Q. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101376 · Cited by 11
A new "single" era of biomedicine and implications in disease research
Hu, C. (2023) · Journal of Bio-X Research · doi:10.1097/jbr.0000000000000140 · Cited by 11
Maurer, A. C., Benyamini, B., Whitney, O. N., Fan, V. B., Cattoglio, C., Kissiov, D. U., Dailey, G. M., Darzacq, X., Weitzman, M. D., & Tjian, R. (2025) · Nature Communications · doi:10.1038/s41467-025-56738-5 · Cited by 9
Metadata
- Authors
- Tornabene, P., Trapani, I., Minopoli, R., Centrulo, M., Lupo, M., de Simone, S., Tiberi, P., Dell’Aquila, F., Marrocco, E., Iodice, C., Iuliano, A., Gesualdo, C., Rossi, S., Giaquinto, L., Albert, S., Hoyng, C. B., Polishchuk, E., Cremers, F. P. M., Surace, E. M., Simonelli, F., De Matteis, M. A., Polishchuk, R., & Auricchio, A.
- Affiliations
- Telethon Institute Of Genetics And Medicine (IT)
- Federico II University Hospital (IT)
- Telethon Institute of Genetics and Medicine (TIGEM), 80078 Pozzuoli, Italy.
- University of Campania "Luigi Vanvitelli" (IT)
- Department of Human Genetics and Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, 6525 Nijmegen, Netherlands.
- Radboud University Nijmegen (NL)
- Corresponding author
- Tornabene, Patrizia
- Trapani, Ivana
- Auricchio, Alberto
- ORCID
- Tornabene, Patrizia
- Trapani, Ivana
- Minopoli, Renato
- Lupo, Mariangela
- Tiberi, Paola
- Dell’Aquila, Fabio
- Marrocco, Elena
- Iuliano, Antonella
- Gesualdo, Carlo
- Rossi, Settimio
- Giaquinto, Laura
- Hoyng, Carel B.
- Polishchuk, Elena
- Cremers, Frans P. M.
- Surace, Enrico M.
- Simonelli, Francesca
- De Matteis, Maria A.
- Polishchuk, Roman
- Auricchio, Alberto
- Venue
- Science Translational Medicine
- Published
- 2019-05-15
- Volume
- 11
- Issue
- 492
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC6863751
- OpenAlex
- W2945064781
- Cited by
- 192
- References
- 53
- Citations by year
- 2026: 23 · 2025: 40 · 2024: 26 · 2023: 27 · 2022: 28 · 2021: 23 · 2020: 20 · 2019: 5
- FWCI
- 11.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- CINECA IRIS Institutional Research Information System (University of Basilicata) (submittedVersion, public-domain)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
- Funders
- Universita degli Studi di Napoli Federico II (STAR Program)
- European Research Council (694323)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- split intein, adeno-associated virus vectors, retinal gene therapy, subretinal delivery, inherited retinal disease, inherited blindness, retinal organoids, porcine model
- MeSH terms
- Dependovirus, Animals, Genetic Vectors, Humans, Organoids, Phenotype, Retina, Swine, Gene Transfer Techniques, Trans-Splicing, Photoreceptor Cells, Vertebrate, Inteins, Green Fluorescent Proteins, Mice, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
